The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn whether atacicept treatment leads to improvement in
kidney function in subjects with active lupus nephritis in combination with mycophenolate
mofetil (MMF) and corticosteroids. The study was sponsored by Merck Serono International;
operational oversight was provided by ZymoGenetics.